As of June 21, 2025, Apotheca Biosciences Inc (CBDC) reports a Current Ratio of 0.12.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Apotheca Biosciences Inc's Current Ratio
Over recent years, Apotheca Biosciences Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2019-01-31 | 0.12 |
| 2018-01-31 | - |
| 2017-01-31 | 0.01 |
| 2016-01-31 | 0.11 |
| 2015-01-31 | 1.31 |
This gradual decrease highlights how Apotheca Biosciences Inc manages its short-term assets and liabilities over time.
Comparing Apotheca Biosciences Inc's Current Ratio to Peers
To better understand Apotheca Biosciences Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Apotheca Biosciences Inc (CBDC) | 0.12 |
| Globex Data Ltd (SWIS.CN) | 73.86 |
| HBP Energy Corp (HBPE) | 11.08 |
| iMining Technologies Inc (IMIN.V) | 6.37 |
| Evolutionary Genomics Inc (FNAM) | 3.92 |
| Unex Holdings Inc (UNEX) | 1.93 |
Compared to its competitors, Apotheca Biosciences Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.